JoVE BLOG | JoVE

Breast Cancer Protocol Reaches UK Newspaper Giant, the Daily Mail

Written by Phil Meagher | Oct 8, 2013 4:00:00 AM

A new technique in breast cancer treatment recently caught the attention of the Daily Mail—the second best-selling newspaper in the United Kingdom.

The headline read, “Could breast cancer soon be treated with a NIPPLE injection? Technique reduces side effects and is more effective,” referring to the exciting experiment published in JoVE on October 1. In the JoVE video, researchers from the Boston Children’s Hospital and Harvard University demonstrate their novel approach to treating such tumors directly—injecting therapeutics into the milk ducts (the most common place breast cancer cells are found) of the mammary gland via the nipple.

Why all the press? Not does this protocol offer express access to breast cancer cells, sparing the body’s healthy cells when used for administering chemotherapy, but the same researchers have also found a means for their procedure in breast cancer prevention; they currently have a method for injecting gene-inhibiting therapeutics, which target breast-cancer causing genes, under review in Science Translational Medicine. The researchers were able to prevent mammary tumors in mice known to “spontaneously develop” them.

If you haven’t done so already, you should check out the Daily Mail article online, or view the protocol itself and its press release on our website.